Share
Market Research Report

EOSINOPHILIC ESOPHAGITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassCorticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole · Esomeprazole · and Others; and Late Stage Pipeline Drugs: Dupixent · APT-1011 · Lirentelimab (AK002) · Cendakimab · Etrasimod · TAK-721 · and Omilancor (BT-11)
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • Published In29 Apr 2026
  • Report CodeCMI4909
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Detailed Segmentation:

  • Global Eosinophilic Esophagitis Market, By Drug Class (Revenue, USD Mn, 2021 - 2033)

    • Corticosteroids
      • Budesonide
        • Jorveza
        • Off-label budesonide
      • Fluticasone
    • Proton Pump Inhibitor (PPI)
      • Omeprazole
      • Esomeprazole
      • Others
    • Late Stage Pipeline Drugs
      • Dupixent
      • APT-1012
      • Lirentelimab (AK002)
      • Cendakimab
      • Etrasimod
      • TAK-721
      • Omilancor (BT-11)
  • Global Eosinophilic Esophagitis Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Eosinophilic Esophagitis Market, By Region (Revenue, USD Mn, 2021 - 2033)

    • North America
      • By Drug Class
        • Corticosteroids
          • Budesonide
            • Jorveza
            • Off-label budesonide
          • Fluticasone
        • Proton Pump Inhibitor (PPI)
          • Omeprazole
          • Esomeprazole
          • Others
        • Late Stage Pipeline Drugs
          • Dupixent
          • APT-1012
          • Lirentelimab (AK002)
          • Cendakimab
          • Etrasimod
          • TAK-721
          • Omilancor (BT-11)
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Drug Class
        • Corticosteroids
          • Budesonide
            • Jorveza
            • Off-label budesonide
          • Fluticasone
        • Proton Pump Inhibitor (PPI)
          • Omeprazole
          • Esomeprazole
          • Others
        • Late Stage Pipeline Drugs
          • Dupixent
          • APT-1012
          • Lirentelimab (AK002)
          • Cendakimab
          • Etrasimod
          • TAK-721
          • Omilancor (BT-11)
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug Class
        • Corticosteroids
          • Budesonide
            • Jorveza
            • Off-label budesonide
          • Fluticasone
        • Proton Pump Inhibitor (PPI)
          • Omeprazole
          • Esomeprazole
          • Others
        • Late Stage Pipeline Drugs
          • Dupixent
          • APT-1012
          • Lirentelimab (AK002)
          • Cendakimab
          • Etrasimod
          • TAK-721
          • Omilancor (BT-11)
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Class
        • Corticosteroids
          • Budesonide
            • Jorveza
            • Off-label budesonide
          • Fluticasone
        • Proton Pump Inhibitor (PPI)
          • Omeprazole
          • Esomeprazole
          • Others
        • Late Stage Pipeline Drugs
          • Dupixent
          • APT-1012
          • Lirentelimab (AK002)
          • Cendakimab
          • Etrasimod
          • TAK-721
          • Omilancor (BT-11)
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug Class
        • Corticosteroids
          • Budesonide
            • Jorveza
            • Off-label budesonide
          • Fluticasone
        • Proton Pump Inhibitor (PPI)
          • Omeprazole
          • Esomeprazole
          • Others
        • Late Stage Pipeline Drugs
          • Dupixent
          • APT-1012
          • Lirentelimab (AK002)
          • Cendakimab
          • Etrasimod
          • TAK-721
          • Omilancor (BT-11)
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Class
        • Corticosteroids
          • Budesonide
            • Jorveza
            • Off-label budesonide
          • Fluticasone
        • Proton Pump Inhibitor (PPI)
          • Omeprazole
          • Esomeprazole
          • Others
        • Late Stage Pipeline Drugs
          • Dupixent
          • APT-1012
          • Lirentelimab (AK002)
          • Cendakimab
          • Etrasimod
          • TAK-721
          • Omilancor (BT-11)
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa